The purpose of this study is to compare the effects on glycemic control of Teleconsultation versus standard visit in outpatient clinic for patients affected by type 1 diabetes mellitus.
The growing incidence of diabetes and the need to contain health care costs empower the necessity to identify new models to cope with regular periodic follow up of patients affected by diabetes mellitus. Telemedicine offers an acknowledged instrument to provide clinical health care at a distance, increasing patient compliance and the achievement of therapeutical goals. This study wants to verify the feasibility and the efficacy of teleconsultation in patients with type 1 diabetes mellitus. In particular by a randomized controlled approach the effects on glycemic control of patients followed by teleconsultation or traditionally in standard visit in the outpatient clinic. The patients in the teleconsultation group will arrange their bookings on a website (http://www.telediabete-fid.it/) In this website they could also access to web educational courses (mainly nutrition, insulin management, glucose monitoring auto-control) or to nutritional and psychological counselling.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Enrollment
150
The patients in the consultation group arranged their bookings on a website, where they could also access to web educational courses or to nutritional and psychological counselling
Group of patients followed in a traditional way
AO Ospedale Civile Legnano Legnano
Legnano, Italy
ASST Grande Ospedale Metropolitano Niguarda
Milan, Italy
glycosylated hemoglobin HbA1c
HbA1c is the main parameter representing the overall glycemic control. HbA1c can be assessed on three month bases but the value at 12 month is more representative of a sustained effect of this new approach
Time frame: 12th month
HbA1c glycosylated hemoglobin
changes of HbA1c glycosylated hemoglobin values
Time frame: 3rd to 6th to 9th month
Patient satisfactory assessment by a questionnaire on their perception of advantages (diabetes management, comfort and convenience) and limits (technical problems, poor interaction with physicians) of the service
A score of 1 (low) to 5 (High) will be used
Time frame: 12th month
Cost analysis by patient estimation through a questionnaire of the overall cost and time saved thanks to the service
The average amount of cost and time saved will be calculated
Time frame: 12th month
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.